相关临床试验
45
15 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
7
15.6%
已完成
22
48.9%
尚未招募
8
17.8%
招募中
5
11.1%
终止
3
6.7%
暂无批准数据
- Singapore is advancing an evidence-based strategy to integrate Traditional Chinese Medicine (TCM) into its mainstream healthcare system, anchored by the Healthier SG national prevention strategy. - One in five adult Singaporeans use TCM annually, and nearly 40% of these individuals combine TCM with Western medicine for the same condition, according to MOH's 2022 National Population Health Survey. - The TCM Integrative Sandbox (TCMIS) initiative, launched in January last year, is testing evidence-based, cost-effective TCM treatments in public hospitals to generate real-world evidence. - Successful integration requires research, education and capability building, and robust governance to advance together, as outlined at the inaugural Singapore-Australia Integrative Medicine Symposium.
- Two New Zealand health unions, NZRDA and APEX, are urging the Ministry of Health and Pharmac to fast-track approval, funding, and distribution of RSV vaccines for at-risk populations. - RSV causes an estimated 2,000 hospitalisations of children under 5 each year in New Zealand, at a cost of roughly $25 million annually. - Immunisations for the elderly, immunocompromised adults, pregnant women, and infants are under consideration by Medsafe but remain unfunded by Pharmac. - Union leaders argue that making RSV vaccination available and free would reduce the burden of seasonal respiratory disease on hospitals and the health system.
- Massachusetts issued an emergency order temporarily classifying all kratom products as Schedule I drugs, with the ban set to take effect after a 14-day notice period. - Four retailers filed a lawsuit in Suffolk County Superior Court arguing DPH Commissioner Robbie Goldstein lacked authority and failed to establish the required statutory findings. - The lawsuit contends the order too broadly targets all kratom products rather than the concentrated and synthetic derivatives posing greater health risks. - Massachusetts has recorded more than 100 kratom-associated deaths since 2020, while the state poison center logged about 130 kratom-related calls from January 2021 through July 2026.
- Vietnam plans to participate in international clinical trials of mRNA-based cancer vaccines beginning in 2026, marking a significant step in the country's advanced biomedical research capabilities. - The initiative is part of implementing the Politburo's Resolution 57 on breakthroughs in science, technology, innovation and national digital transformation, with collaboration planned with international partners including Russia and France. - Vietnam is simultaneously accelerating technology transfer agreements, including an expected cooperation with Sanofi to produce three types of vaccines domestically using modern French manufacturing technologies. - The health sector is also prioritizing advanced therapies including CAR-T cell therapy and stem cell therapy through cooperation with Japan, alongside AI integration in gene sequencing for cancer treatment.
- Iran has risen from 12th to 7th place globally in regenerative medicine following approval of six new Advanced Therapy Medicine Products (ATMP) by regulatory authorities. - The approved products span cell therapy, tissue engineering, and CAR-T therapy, targeting critical conditions including vitiligo, graft-versus-host disease, cerebral palsy, burns, diabetic foot ulcers, osteoarthritis, and leukemia. - Iran now holds seven of the world's 148 licensed ATMP products, representing a dramatic increase from just one product available in March 2023 to seven by March 2025. - The achievement positions Iran among the top 10 countries in advanced regenerative medicine and establishes potential for the nation to become a regional hub with export capabilities.
- Singapore has launched Phase III of its National Precision Medicine programme, aiming to enroll 400,000-450,000 patients from healthcare settings over the next five years to study genomic information in real-world clinical care. - The programme will transition from studying healthy populations to working with patients receiving medical treatment, enabling researchers to understand how genetic, lifestyle and environmental factors interact in clinical settings. - The Ministry of Health is providing financial support for genetic tests, with familial hypercholesterolemia testing costing less than $100 out-of-pocket after subsidies, and has extended insurance protection to prevent genetic discrimination. - Upon completion, over 500,000 participants representing 10% of Singapore's resident population will have undergone whole genome sequencing, positioning the nation as a leader in Asian precision medicine research.
- Stella's stellate ganglion block treatment demonstrates superior efficacy with 68-78% success rates compared to traditional PTSD therapies that succeed less than half the time. - The minimally invasive procedure involves injecting local anesthetic into nerve bundles at the neck base, providing immediate symptom relief by resetting the sympathetic nervous system. - Clinical data from over 280 patients shows significant improvements in anxiety scores, with Israeli patients experiencing average PCL score drops from 51 to 33 points. - The treatment has gained regulatory approval in Israel and receives philanthropic funding, with soldiers now fully covered by the Defense Ministry following October 7 conflict.
- Saudi Arabia inaugurated its first-ever national pavilion at BIO International Convention 2025 in Boston, showcasing its ambition to become a global biotechnology hub under Vision 2030. - The Kingdom signed multiple partnership agreements with global biotech leaders including Vertex Pharmaceuticals for precision medicine and Illumina for genomics research. - The initiative represents a comprehensive biotech ecosystem spanning regulation, research, infrastructure, and investment, supported by streamlined clinical trial approvals and digital health platforms. - Saudi Arabia's integrated approach brings together government entities, research institutions, and investment facilitators to accelerate biotech innovation and localize advanced therapeutic solutions.
- The Kenyan Ministry of Health has partnered with Roche East Africa to reduce breast cancer treatment costs from Sh120,000 to Sh40,000 per session, representing a 67% cost reduction. - The agreement eliminates co-payments for patients at all Social Health Authority-accredited facilities, including public, faith-based, and private hospitals. - This initiative addresses a critical need as breast cancer affects 6,799 women annually in Kenya and accounts for 23.3% of all cancer diagnoses among women. - The partnership aims to strengthen Kenya's cancer care framework by improving access to essential medicines, enhancing healthcare professional capacity, and expanding screening programs.
- Argentina's Ministry of Health announced a comprehensive review of fast-track authorization policies for high-cost medications, particularly those targeting pediatric populations and rare diseases. - The government will implement mandatory placebo-controlled clinical studies as the minimum scientific standard for all future vaccine trials to enhance scientific rigor. - These policy changes prioritize patient safety and healthcare system sustainability while maintaining that innovation should not justify rushed approval decisions without solid evidence. - The reforms aim to strengthen evidence foundations and boost public confidence in Argentina's regulatory framework through enhanced scientific standards.
